SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-23-001071
Filing Date
2023-02-15
Accepted
2023-02-15 16:05:41
Documents
77
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ipix_10q.htm   iXBRL 10-Q 1264446
2 CERTIFICATION ipix_ex311.htm EX-31.1 8324
3 CERTIFICATION ipix_ex321.htm EX-32.1 3185
  Complete submission text file 0001477932-23-001071.txt   5924441

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ipix-20221231.xsd EX-101.SCH 88792
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipix-20221231_lab.xml EX-101.LAB 363631
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ipix-20221231_cal.xml EX-101.CAL 52996
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipix-20221231_pre.xml EX-101.PRE 323142
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ipix-20221231_def.xml EX-101.DEF 232030
71 EXTRACTED XBRL INSTANCE DOCUMENT ipix_10q_htm.xml XML 902425
Mailing Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880
Business Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880 978-921-4125
Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 300565645 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-37357 | Film No.: 23635370
SIC: 2834 Pharmaceutical Preparations